The 40th Anniversary Meeting of the ISRAEL SOCIETY of
DERMATOLOGY & VENEREOLOGY

May 15-17, 2019. The Dan Hotel, Eilat, Israel

07:00 – 08:00

Registration & Welcome Reception, and visit the Exhibition Area
08:00 – 10:20

GIDV Meeting – Session 1

(Hall A)

Chairs: R. Bergman, P. Lehman.

08:00 – 08:20

An  opening  ceremony  of  GIDV  society  meeting

08:20 – 08:30

Lehmann P.    Past, present and  future of the GIDV

08:30 – 08:50

Thomas P.    Allergy to implants

08:50 – 09:00

Baum S.    Recurrent rituximab therapy in pemphigus as a disease modifier

09:00 – 09:15

Emmert S.    New insights in photocarcinogenesis

09:15 – 09:30

Zvulunov A.    Life-threatening bleeding from cutaneous vascular tumors in infants

09:30 – 09:40

 Kridin K.    The epidemiology of pemphigus in Israel

09:40 – 09:50

Rode S.    Development of a melanoma nine years after excision of a dysplastic nevus

09:50 – 10:10

 Coffee Break – and visit the Exhibition Area
10:10 – 11:50

GIDV Meeting – Session 2

(Hall A)

Chairs: R. Bergman, P. Lehman.

10:10 – 10:30

Hodak E.    The role of microRNAs in mycosis fungoides- from bench to bedside

10:30 – 10:40

Hofmann S.    Persisting pain after an inguinal hernia repair. Could it be an allergy?

10:40  – 10:50

Dodiuk-Gad R.    Darier disease – new insights

10:50 – 11:00

Kreuter A.    Unusual presentations of HPV dermatoses

11:00 – 11:10

Goldsmith T.    Nail dystrophy: not what you may think

11:10 – 11:20

Sezin T. Dual inhibition of complement factor C5 and leukotriene B4 by means of a bifunctional biotherapeutic synergizes in suppressing murine pemphigoid disease

11:20 – 11:30

Kohl P.    Dr. E. Langer – One who came back

11:30 – 11:40

Goldberger T.    Combined pharmacological and surgical therapy for PASH syndrome

11:40 – 11:50

Closing

11:50 – 13:30

Lunch, Registration, Accommodation & visit at the Exhibition
13:30 – 15:00

ISDV Meeting

(Hall A)

Chairs: S. Halevy, M. David, H. Trau, A. Ingber

13:00 – 13:20

Opening

13:20 – 13:35

Maurer M.    Chronic urticaria – Problems and Solutions

Sponsored By Novartis

13:40 – 13:55

Blauvelt A.    Il-23 inhibitors: From clinical data to clinical experience

Sponsored By Janssen

14:00 – 14:15

Yosipovitch G.    Management of Itch in Atopic Dermatitis

14:20 – 14:35

Gooderham M.  New horizon in Psoriasis treatment – clinical practice and experience

Sponsored By Abbvie

14:40 – 14:55

Wollenberg A.  Microinflammation in Atopic Dermatitis at the Edge of the Biological Revolution

Sponsored By Perrigo

15:00 – 15:30

Coffee Break – and visit the Exhibition Area

Parallel Sessions

15:30 – 17:35

Parallel Session 1

(Hall A)

Chairs: A. Zlotogorski, Y. Yerushalmi, R. Dodiuk – Gad, A. Gilhar

15:30 – 15:45

Levi A.    PDT in Medical Dermatology

Sponsored By Perigo

15:50 – 16:05

Zlotogorski A.    Treatment of Alopecia Areata – What’s Hot and What’s Not

16:10  – 16:20

Lyakhovitsky A.    Alopecia areata: a long-term follow-up study of 104 patients

16:25 – 16:35

Laufer R.B.    Therapeutic effects of apremilast versus tofacitinib in The humanized mouse model of alopecia areata

16:40  – 16:50

Dodiuk-Gad R.    The cutaneous manifestations of Darier disease proposing a new disease classification – a cohort study of 76 patients

16:55- 17:05

Dodiuk-Gad R.    The extra-cutaneous findings in darier disease- a cohort study of 76 patients

17:10 – 17:20

Akerman L. Scar correction with non-ablative fractional Q-switched 1064-nm laser

17:25 – 17:35

Artzi O.  The use of dermal fillers in patients with autoimmune connective tissue diseases

17:35 – 17:45

Artzi O. A treatment protocol for botulinum toxin injections in the treatment of pachyonychia congenita-associated keratoderma

Parallel Session 2

(Hall C)

Chairs: M. Ziv, S. Baum, Y. Leshem, E. Avitan-Hersh.

15:30 – 15:45

Kessel A.    The Good the Bad and Ugly in Antihistamine Treatment

Sponsored By Rafa

15:50 – 16:05

Pesach-Molcho V. Mimickers of Atopic Dermatitis in children

16:10 – 16:20

Leshem Y.    Dupilumab for atopic dermatitis: does real-life differ from clinical studies?

16:25 – 16:35

Rubin Ben Yoav A.    Adult atopic dermatitis in hospitalized patients: comparison between those with childhood-onset to late-onset disease

16:40 – 16:50

Yosipovitch G.    The Effect of Crisaborole Ointment, 2%, on Pruritus in Patients With Atopic Dermatitis (AD): An Extended Analysis

16:55 – 17:05

Sarig O. Expanding the clinical spectrum of erythrokeratolysis hiemalis

17:10 – 17:20

Peled A.    Dual role of card14 in atopic dermatitis and psoriasis

17:25 – 17:35

Sabbah F.    Skin microbiome compositional changes in atopic dermatitis patients accompany dead sea climatotherapy

19:30 – 21:30

Get Together Reception & Dinner with Spouses
07:30 – 08:30
Faculty breakfast -Meet the professors:  Moderator:  Blauvelt A

Parallel Sessions

8:45- 11:00

Session 3

(Hall A)

Chairs: S. Halevy, M. Solomon, I. Amitay-Laish.

08:45 – 09:00

Halevy S.    Drug-induced nail disorders

09:05 – 09:15

Dias-Polak D.    Follicular rashes with folliculotropic lymphocytic infiltrates associated with anti tnf-α therapy & calcineurin inhibitors: clinical, histopathological, immunohistochemical and molecular study

09:20 – 09:30

Neuman MG.    Severe Cutaneous Adverse Reactions to Ibuprofen: Medical and Laboratory Causality-Assessment

09:35 – 09:45

Dodiuk-Gad R.    Knowledge and opinions among canadian academic physicians regarding genetic screening to prevent severe cutaneous adverse drug reactions

09:50 – 10:00

Lussheimer S.    Cutaneous adverse events under inhibition of programmed cell death-1 immunotherapy in metastatic melanoma As a prognostic marker

10:05 – 10:15

Zidan O.    Folliculotropic mycosis fungoides-like drug eruption-a new cutaneous adverse effect of Adalimumab

10:20 – 10:30

Amitay-Laish I.    Does immune-biologic treatment given for inflammatory diseases, alter the course of mycosis fungoides? a multicenter study of “real-life”

10:30 – 10:45

Dodiuk-Gad R.    Drug eruptions – when to worry?

10:50 – 11:00

Arbiser J.     Propranolol exhibits activity against hemangiomas independent of beta- blockade

Session 4

(Hall B)

Chairs: R. Bergman , L. Samuelov, Y. Valdman-Grinshpoun

08:45 – 09:00

Bergman R.    Pseudolymphomatous skin reactions

09:05 – 09:20

Avitan-Hersh E.    BRAF inhibitors in the era of immune checkpoint blockade

09:25 – 09:35

Sherman S.    Mycosis fungoides is associated with melanoma – a cross-sectional study

09:40 – 09:50

Schachter O.     Evaluation of pcr-based tcr-β clonality test In the diagnosis of early mf

09:55 – 10:05

Isman Nelkenbaum G.    Dermoscopic features of eb nevi

10:10 – 10:20

Avitan-Hersh E.    Low grp78 protein level predicts response to pd1 therapy and good prognosis in melanoma

10:25 – 10:35

Naimer S.    Video dermatoscopy in a thriving dermatology practice

10:35 – 10:45

Gluck M.    mTOR inhibitors are effective in secondary prevention of non-melanoma skin cancers in solid organ transplant recipients

10:45 – 10:55

Leshem Y.    The diagnostic accuracy of dermoscopy for basal cell carcinoma: a systematic review and meta-analysis

Session 5

(Hall C)

Chairs: E. Sprecher, D. Ben Amitai, Y. Mashiah

08:45 – 09:00

Sprecher E.    Scratching off the genetics of skin inflammatory diseases 

09:05 – 09:20

 Remitz A.    Revisiting topical Calcineurin Inhibitors for Atopic Dermatitis

Sponsored By Dexcel Pharma

09:25 – 09:35

Koren A.    The efficacy of combined diluted calcium hydroxylapatite-based filler and an energy-based device in the treatment of facial Atrophic acne scars

09:40 – 09:55

Ziv M.    Biologic therapy for psoriasis- the comorbidities perspective

Sponsored By Lilly

10:00 – 10:15

 Kircik L.    The importance of skin identical ceramides and MVE delivery technology to restore and maintain skin barrier function

Sponsored By CeraVe

10:20 – 10:30

Laufer RB.    Possible role of ILC1 in the pathogenesis of alopecia areata.

Research Award Candidate

10:35 – 10:45

Malki L.    Deciphering the pathogenesis of central centrifugal cicatricial alopecia

10:50 – 11:00

Tseytlin A.    Online educational intervention for parents of children with atopic dermatitis as a part of a doctor’s official recommendation: first impressions on atopicschool.ru

11:00 – 11:30
Coffee Break – and visit the Exhibition Area

Parallel Sessions

11:30- 13:30

Session 6

(Hall A)

Chairs: D. Mimouni, H. Matz, A. Horev

11:30 – 11:45

Mimouni D.    Diagnosis and Management of Pemphigus: recommendations by an International Panel of Experts

11:50 – 12:00

Segal O.    Illness perception, social support, distress and dermatological quality of life of pemphigus vulgaris patients

12:05- 12:15

Hammad H.   Mutation in dsg4 underlies autosomal recessive keratosis pilaris atrophicans

Research Award Candidate

12:15- 12:30

Ingber A.    Palmar Psoriasis – pitfalls in management


Sponsored By Neopharm Israel

12:35 – 12:50

Matz H.    Infectious diseases and psoriasis

12:55 – 13:05

Kridin k.    Mucosal Involvement in Bullous Pemphigoid: A Prevalence Study

13:05 – 13:15

Kridin k. Dipeptidyl-peptidase IV inhibitors-associated bullous pemphigoid: A case-control study, systematic review, and meta-analysis

Research Award Candidate

13:20 – 13:30

Tagar Sar-el M.    Management of bp patients: comparison of classic bullous pemphigoid (bp) to non-bullous bp

Session 7

(Hall B)

Chairs: A. Scope, E. Azizi, B. Kaplan

11:30 – 11:45

Azizi E.    What’s New in Familial Melanoma

11:50 – 12:00

Warshavsky K.    Timp3 overexpression in cutaneous Graft versus Host Disease

12:05 – 12:20

Davidovici B.  NMSC – medical therapy & prevention

NMSC – medical therapy & prevention

12:25 – 12:35

Raiber S.    The role of rnf4 in cutaneous squamous cell carcinoma

12:40 – 12:55

Cohen J. Surviving Cutaneous Melanoma: Follow-up Practices, Surveillance and Management

 

Sponsored By MSD

13:00 – 13:10

Kaplan B.    Reconstruction of Forehead Surgical Wounds

13:15 – 13:30

Scope A.    New guidelines for diagnosis and management of cutaneous melanoma

Session 8

(Hall C)

Chairs: A. Barzilai, M. David, Y. Ramot

11:30 – 11:45

Hodak E.    Topical treatments for MF-CTCL

 

Sponsored By Rafa

11:50 – 12:05

Barzilai A.    BCC induced by therapeutic radiation for tinea capitis

12:10 – 12:25

Pavlotsky F.   Maintenance phototherapy – why, when and for whom?

12:30 – 12:40

Amitay-Laish I.    The therapeutic potential of cannabinoids from cannabis sativa extracts for mycosis fungoides / sézary syndrome – an in vitro and ex vivo study

12:45 – 12:55

Pavlovsky M.    Enpp1: the missing link between calcification, keratinization and pigmentation

13:00 – 13:10

Mohammed J.    Betulinic acid: pre-clinical evidence for its efficacy in peeling skin syndromes

13:15 – 13:30

Snast I.    Epidemiology of cutaneous porphyria in israel: a nationwide cohort study

13:30 – 14:30
LUNCH – and visit the Exhibition Area
14:30 – 15:40

PLENARY #2

(Hall A)

Chairs: E. Hodak, H. Trau, A. Ingber

14:30 – 14:45

Gooderham M.   The importance of “PASI 90/100”

Sponsored By Abbvie

14:50 – 15:05

Aletaha D.    Psoriasis – not just a skin disease: a look through the eyes of the  rheumatologist

Sponsored By Novartis

15:10 – 15:40

Blauvelt A.    Role of IL-23 in psoriasis pathogenesis

Sponsored By Janssen

15:40 – 16:00
Coffee break – and visit the Exhibition Area

Parallel Sessions

16:00- 17:45

Session 9

(Hall A)

Chairs: I. Goldberg, V. Molho Pessach, R. Friedland

16:00 – 16:15

Segal R.    Treatment paradigms in Rosacea

16:20 – 16:35

Haffner A.  Hidradenitis Suppurativa

16:40 – 16:55

Trattner A.    Contact dermatitis in children

17:00 – 17:10

Samuelov L.    Revisiting pachyonychia congenita: a case cohort study in 815 patients

17:15 – 17:30

Nevet J.    Is there a genetic basis for contact dermatitis?

17:35 – 17:45

TBD

Session 10

(Hall B)

Chairs: A.Levi, L. Horev L, B. Davidovici
.

16:00 – 16:15

Koren A.    Energy-based devices for the treatment of skin infectious diseases

16:20 – 16:35

TBD

16:40 – 16:50

Shehadeh W.    Attenuation of post-lumpectomy scars using a combination of pulsed dye
laser and co2 fractional ablative laser: a split scar comparative study

16:55 – 17:05

Snast I.    Pulsed dye laser combined with systemic retinoids for treatment of
resistant hypertrophic warts among organ transplant patients

17:10 – 17:20

Bar J.    Skin microbiome characteristics of dystrophic epidermolysis bullosa (DEB)
patients

Research Award Candidate

17:25 – 17:35

Sheffer-Levi S.    Isolation and characterization of Propionobacterium acnes strains from
israeli Acne patients

Research Award Candidate

Session 11

(Hall C)

Chairs: L. Pavlovsky, I. Shelkovitz, I. Tsyrulnikov

16:00 – 16:15

Gieler U.   Psychological aspects & burden of Atopic Dermatitis

Sponsored By Sanofi

16:20 – 16:35

Shemer A.    Onychoscopy – a practical tool for diagnosis of nail abnormalities

16:40 – 16:55

Pavlovsky M.    Vitiligo: has the bench reached the bedside

17:00 – 17:10

Pavlovsky L.    Il-17a inhibitor switching – efficacy of ixekizumab following secukinumab failure. A one-year single-centre experience

17:15 – 17:25

Shelkovitz T.    Platelet rich plasma (P.R.P) – The ultimate filler

17:30 – 17:40

Gur S.   Burnout among dermatologists in israel

19:45 – 21:30
Departure from the lobby of the Dan Hotel Eilat  to the “Gala Dinner”

Plenary #3

(Hall A)

Chairs: E. Hodak, D. Mimouni, Y. Ramot

08:00 – 08:45

Professional meeting of the ISDV

Parallel Sessions

9:00- 11:00

Session 12

(Hall A)

Chairs: A. Shemer, R. Segal, M. Landau

חוג למחלות ציפורניים

09:00 – 09:15

Shemer A.    Psoriasis & Fungal Infections.

09:20 – 09:35

Segal R.    Management of challenging cases in a dermatomycosis clinic.

09:40 – 09:55

Shemer A.    Is there indeed as epidemic tinea capitis due to T.tonsurase in israel?

10:00 – 10:15

Goldsmith T.    Shedding light on (and under) the nail – a review of clinical cases from the Tel Aviv Medical Center.

10:20 – 10:35

Shemer A.New study parameters in onychomycosis.

10:40 – 10:50

TBD

Session 13

(Hall C)

Chairs: D. Hallel-Halevy, F. Pavlotsky, N. Nathanson

חוג פסוריאזיס ודרמוסקופיה

09:00 – 09:15

Pavlotsky F.    Phototherapy, Moles and Skin Cancer

09:20 – 09:35

Scope A.    Basic dermoscopic features in inflammatory skin diseases

09:40 – 09:55

Feuerman H.    Dermoscopic diagnosis of papulo-squammous and other skin diseases

10:00 – 10:15

Pavlovsky L.    Immuno-suppressive & immuno-modulatory drugs and risk for melanoma

10:20 – 10:35

Matz H.    Biologic therapy for psoriasis and risk of malignancy

10:40 – 10:55

Nathanson N.    Identification of vascular patterns in dermoscopic diagnosis of skin cancer.

11:00 – 11:30
Brunch – and visit the Exhibition Area
11:30 – 12:30

Plenary Session 5 – Awards

(Hall A)

Chairs: M. Grunwald, H. Trau, D. Ben Amitai, M. David, A. Gilhar

11:30 – 11:40

Best Art work

11:40 – 11:50

Best Case of the year

11:50 – 12:00

Best Poster

12:00 – 12:20

Best Research

12:20 – 12:30

Participation Awards

12:30

Adjurn